Leafly Holdings Retained Earnings (Accumulated Deficit) 2020-2024 | LFLY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Leafly Holdings retained earnings (accumulated deficit) from 2020 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Leafly Holdings Retained Earnings (Accumulated Deficit) 2020-2024 | LFLY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$202.6B
Stryker (SYK)	$144.4B
Boston Scientific (BSX)	$130.4B
Medtronic (MDT)	$113.2B
EssilorLuxottica (ESLOY)	$112.1B
Lonza Group Ag (LZAGY)	$45.3B
Haleon (HLN)	$43B
GE HealthCare Technologies (GEHC)	$39B
ResMed (RMD)	$36.5B
Terumo (TRUMY)	$30.6B
Koninklijke Philips (PHG)	$24.9B
Zimmer Biomet Holdings (ZBH)	$21.8B
Insulet (PODD)	$19.3B
Baxter (BAX)	$17.5B
Smith & Nephew SNATS (SNN)	$10.8B
Bio-Rad Laboratories (BIO)	$10.2B
BellRing Brands (BRBR)	$9.2B
Demant (WILYY)	$8.4B
Lantheus Holdings (LNTH)	$5.8B
TG Therapeutics (TGTX)	$4.8B
Haemonetics (HAE)	$4.6B
ICU Medical (ICUI)	$4.4B
Prestige Consumer Healthcare (PBH)	$4B
Perrigo (PRGO)	$3.6B
Envista Holdings (NVST)	$3.6B
Neogen (NEOG)	$3.6B
Agios Pharmaceuticals (AGIO)	$3.4B
GN Store Nord (GNNDY)	$3.1B
Shandong Weigao Medical Polymer (SHWGF)	$3B
QuidelOrtho (QDEL)	$2.9B